FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches

Ciljana isporuka antiinflamatornih lekova u donje delove gastrointestinalnog trakta - konvencionalni i savremeni pristupi

Thumbnail
2017
2931.pdf (450.4Kb)
Authors
Čalija, Bojan
Milić, Jela
Article (Published version)
Metadata
Show full item record
Abstract
The therapy of inflammatory bowel diseases can be improved by development of new effective and selective biological drugs and efficiency improvement of existing, traditional anti-inflammatory drugs via targeting sites of inflammation. Targeted drug delivery upon peroral administration results in improved therapeutic efficacy, reduction of systemic side effects, decreases risk of drug to drug interactions, and in case of prolonged-release systems improves compliance/adherence by reduced frequency of drug intake. This article describes two approaches for targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: conventional, based on specific physiological conditions of different parts of gastrointestinal tract (pH, enzymatic activity of intestinal flora and transit time) and novel, based on micro- and nanoencapsulation (e.g. polymeric and lipid micro- and nanoparticles, liposomes), with focus on the anti-inflammatory drugs intended for targeted delivery in l...ower parts of gastrointestinal tract available on market of Republic of Serbia.

Poboljšanje efikasnosti terapije inflamatornih bolesti creva postiže se razvojem novih, efikasnih i selektivnih bioloških lekova, ali i unapređenjem efikasnosti postojećih, tradicionalnih antiinflamatornih lekova, putem ciljane isporuke na mesto inflamacije. Ciljanom isporukom na mesto inflamacije nakon peroralne primene postiže se veća terapijska efikasnost, smanjuju sistemski neželjeni efekti leka i rizik od interakcije sa drugim lekovima, a kod sistema sa produženim oslobađanjem poboljšava i komplijansa/adherenca usled smanjenja učestalosti doziranja. U ovom radu su opisane dve grupe pristupa za postizanje ciljane isporuke antiinflamatornih lekova u donje delove gastrointestinalnog trakta: konvencionalni, zasnovani na fiziološkim specifičnostima različitih delova gastrointestinalnog trakta (pH vrednost, enzimska aktivnost crevne flore i tranzitno vreme, odnosno njihova kombinacija) i savremeni, koji se zasnivaju na inkapsulaciji lekovitih supstanci u mikro- i nanonosače (npr. polime...rne i lipidne mikro- i nanočestice i liposome), sa posebnim osvrtom na antiinflamatorne lekove za ciljanu isporuku u donje delove gastrointestinalnog trakta prisutne na tržištu Republike Srbije.

Keywords:
inflammatory bowel disease / anti-inflammatory drugs / colon / targeted delivery / inflamatorne bolesti creva / antiinflamatorni lekovi / kolon / ciljana isporuka
Source:
Arhiv za farmaciju, 2017, 67, 2, 124-142
Publisher:
  • Savez farmaceutskih udruženja Srbije, Beograd
Funding / projects:
  • Development of micro- and nanosystems as carriers for drugs with anti-inflammatory effect and methods for their characterization (RS-34031)

DOI: 10.5937/arhfarm1702124C

ISSN: 0004-1963

Scopus: 2-s2.0-85065142768
[ Google Scholar ]
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/2933
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Čalija, Bojan
AU  - Milić, Jela
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2933
AB  - The therapy of inflammatory bowel diseases can be improved by development of new effective and selective biological drugs and efficiency improvement of existing, traditional anti-inflammatory drugs via targeting sites of inflammation. Targeted drug delivery upon peroral administration results in improved therapeutic efficacy, reduction of systemic side effects, decreases risk of drug to drug interactions, and in case of prolonged-release systems improves compliance/adherence by reduced frequency of drug intake. This article describes two approaches for targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: conventional, based on specific physiological conditions of different parts of gastrointestinal tract (pH, enzymatic activity of intestinal flora and transit time) and novel, based on micro- and nanoencapsulation (e.g. polymeric and lipid micro- and nanoparticles, liposomes), with focus on the anti-inflammatory drugs intended for targeted delivery in lower parts of gastrointestinal tract available on market of Republic of Serbia.
AB  - Poboljšanje efikasnosti terapije inflamatornih bolesti creva postiže se razvojem novih, efikasnih i selektivnih bioloških lekova, ali i unapređenjem efikasnosti postojećih, tradicionalnih antiinflamatornih lekova, putem ciljane isporuke na mesto inflamacije. Ciljanom isporukom na mesto inflamacije nakon peroralne primene postiže se veća terapijska efikasnost, smanjuju sistemski neželjeni efekti leka i rizik od interakcije sa drugim lekovima, a kod sistema sa produženim oslobađanjem poboljšava i komplijansa/adherenca usled smanjenja učestalosti doziranja. U ovom radu su opisane dve grupe pristupa za postizanje ciljane isporuke antiinflamatornih lekova u donje delove gastrointestinalnog trakta: konvencionalni, zasnovani na fiziološkim specifičnostima različitih delova gastrointestinalnog trakta (pH vrednost, enzimska aktivnost crevne flore i tranzitno vreme, odnosno njihova kombinacija) i savremeni, koji se zasnivaju na inkapsulaciji lekovitih supstanci u mikro- i nanonosače (npr. polimerne i lipidne mikro- i nanočestice i liposome), sa posebnim osvrtom na antiinflamatorne lekove za ciljanu isporuku u donje delove gastrointestinalnog trakta prisutne na tržištu Republike Srbije.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches
T1  - Ciljana isporuka antiinflamatornih lekova u donje delove gastrointestinalnog trakta - konvencionalni i savremeni pristupi
VL  - 67
IS  - 2
SP  - 124
EP  - 142
DO  - 10.5937/arhfarm1702124C
ER  - 
@article{
author = "Čalija, Bojan and Milić, Jela",
year = "2017",
abstract = "The therapy of inflammatory bowel diseases can be improved by development of new effective and selective biological drugs and efficiency improvement of existing, traditional anti-inflammatory drugs via targeting sites of inflammation. Targeted drug delivery upon peroral administration results in improved therapeutic efficacy, reduction of systemic side effects, decreases risk of drug to drug interactions, and in case of prolonged-release systems improves compliance/adherence by reduced frequency of drug intake. This article describes two approaches for targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: conventional, based on specific physiological conditions of different parts of gastrointestinal tract (pH, enzymatic activity of intestinal flora and transit time) and novel, based on micro- and nanoencapsulation (e.g. polymeric and lipid micro- and nanoparticles, liposomes), with focus on the anti-inflammatory drugs intended for targeted delivery in lower parts of gastrointestinal tract available on market of Republic of Serbia., Poboljšanje efikasnosti terapije inflamatornih bolesti creva postiže se razvojem novih, efikasnih i selektivnih bioloških lekova, ali i unapređenjem efikasnosti postojećih, tradicionalnih antiinflamatornih lekova, putem ciljane isporuke na mesto inflamacije. Ciljanom isporukom na mesto inflamacije nakon peroralne primene postiže se veća terapijska efikasnost, smanjuju sistemski neželjeni efekti leka i rizik od interakcije sa drugim lekovima, a kod sistema sa produženim oslobađanjem poboljšava i komplijansa/adherenca usled smanjenja učestalosti doziranja. U ovom radu su opisane dve grupe pristupa za postizanje ciljane isporuke antiinflamatornih lekova u donje delove gastrointestinalnog trakta: konvencionalni, zasnovani na fiziološkim specifičnostima različitih delova gastrointestinalnog trakta (pH vrednost, enzimska aktivnost crevne flore i tranzitno vreme, odnosno njihova kombinacija) i savremeni, koji se zasnivaju na inkapsulaciji lekovitih supstanci u mikro- i nanonosače (npr. polimerne i lipidne mikro- i nanočestice i liposome), sa posebnim osvrtom na antiinflamatorne lekove za ciljanu isporuku u donje delove gastrointestinalnog trakta prisutne na tržištu Republike Srbije.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches, Ciljana isporuka antiinflamatornih lekova u donje delove gastrointestinalnog trakta - konvencionalni i savremeni pristupi",
volume = "67",
number = "2",
pages = "124-142",
doi = "10.5937/arhfarm1702124C"
}
Čalija, B.,& Milić, J.. (2017). Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 67(2), 124-142.
https://doi.org/10.5937/arhfarm1702124C
Čalija B, Milić J. Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches. in Arhiv za farmaciju. 2017;67(2):124-142.
doi:10.5937/arhfarm1702124C .
Čalija, Bojan, Milić, Jela, "Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches" in Arhiv za farmaciju, 67, no. 2 (2017):124-142,
https://doi.org/10.5937/arhfarm1702124C . .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB